Characteristics of Nurse-Reported Adverse Events: An Exploration Based on FAERS Data
Jieyu Mao, Miyae Yamakawa, Yasushi Takeya

TL;DR
This study analyzes nurse-reported adverse events using FAERS data, highlighting their role in pharmacovigilance and the quality of their reports.
Contribution
The study quantifies the unique contributions of nurses in AE reporting and identifies opportunities to enhance their involvement.
Findings
Nurses reported AEs with the shortest time from event to reporting (247.8 days) and highest VigiGrade scores.
11.82% of reported AE symptoms were not found in the SIDER database, indicating potential unknown adverse drug reactions.
Nurse reports focused on general disorders and tumor-related indications, but their role in pharmacovigilance remains underutilized.
Abstract
Adverse events (AEs) are undesirable experiences linked to medical product use, particularly in aging populations with polypharmacy. Nurses play a critical role in AE reporting due to their close involvement in patient care and medication administration. This study used the FDA Adverse Event Reporting System (FAERS) database to analyze the characteristics of nurse-reported AEs and highlight nurses’ role in pharmacovigilance. Data from the Side Effect Resource (SIDER) database were integrated to assess the proportion of unknown adverse drug reactions in reported AEs, while report quality and completeness were evaluated using the VigiGrade scoring system, a method for assessing the quality of individual case safety reports. After extraction and deduplication, 8,653 nurse-submitted reports were analyzed, with the majority concentrated between 2012 and 2014, accounting for only 5% of all…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsPharmacovigilance and Adverse Drug Reactions · Patient Safety and Medication Errors · Meta-analysis and systematic reviews
